APA (7th ed.) Citation

N, M., XY, Z., LP, X., XH, Z., Y, W., XD, M., . . . YJ, C. (2026). Desensitization Therapy Using Sirolimus and Anti-CD20 Monoclonal Antibody Based Regimen In Haploidentical Transplant Recipients Positive for Donor-Specific Anti-HLA Antibodies. Transplantation and cellular therapy, 32(6), 713.e1-713.e8. https://doi.org/10.1016/j.jtct.2026.01.037

Chicago Style (17th ed.) Citation

N, Ma, et al. "Desensitization Therapy Using Sirolimus and Anti-CD20 Monoclonal Antibody Based Regimen In Haploidentical Transplant Recipients Positive for Donor-Specific Anti-HLA Antibodies." Transplantation and Cellular Therapy 32, no. 6 (2026): 713.e1-713.e8. https://doi.org/10.1016/j.jtct.2026.01.037.

MLA (9th ed.) Citation

N, Ma, et al. "Desensitization Therapy Using Sirolimus and Anti-CD20 Monoclonal Antibody Based Regimen In Haploidentical Transplant Recipients Positive for Donor-Specific Anti-HLA Antibodies." Transplantation and Cellular Therapy, vol. 32, no. 6, 2026, pp. 713.e1-713.e8, https://doi.org/10.1016/j.jtct.2026.01.037.